Psychopharmacological Drugs Advisory Committee

The New England Journal of Medicine asked one of the panel members of the FDA Psychopharmacological Drug Advisory Committee, physician and epidemiologist Thomas B. Newman (2004), to comment on the results of the studies conducted in the controlled clinical trials to determine the risk of suicidality. He wrote,... 

Food and Drug Administration. (1984, February 24). Transcript of Psychopharmacologic Drugs Advisory Committee 26th Meeting. Rockville, MD Author. 

Pharmaceutical Science Drugs Advisory Committee Psychopharmacologic Drugs Advisory Committee Pulmonary Allergy Drugs Advisory Committee Reproductive Health Drugs Advisory Committee... 

FDA Psychopharmacological Drugs Advisory Committee. Briefing Document of Zeldox Capsules (Ziprasidone HCI) 19 July 2000 www.fda.gov/ohrms/dockets/acOO/backgrd/ 361bla.pdf 19/07/2000. 

FDA. FDA briefing document for the Psychopharmacologic Drugs Advisory Committee (meeting), http //www.fda.gov/ohrms/dockets/ac/06/briefing/ 2006-4272bl-01-FDA.pdf, December 13,2006. Accessed August 7,2014. 

Background Package from Pfizer Inc for September 13-14, 2004 Psychopharmacological Drugs Advisory Committee of the Food and Drug Administration, U.S. Food and Drug Administration. 

Venlafaxine presentation to the Food and Drug Administration Psychopharmacology Advisory Committee. Washington, DC, April 1993. 

---